$INO My 10 year experience with Inovio is the ER is uneventful as it relates to any big PR, they will miss all targeted financial projections and it will again be filled with what they are going to do and next to zero on what they have done. In short it will be a non event for us longs and will likely add some fodder for the shorts.
@Wiskerbisquet57 I agree, but I never put much hope in ER as a needle mover on any small bio companies! I have several, results in their research and progress is what I’m interested in. If ER noise was important to me I be in BIG pharma. Own this stock 3+ years, I would point out that I’ve never seen so many big whales buying! That’s interesting to me! JP Morgan, Blackrock ect..